23 Middle East Respiratory Syndrome coronavirus (MERS-CoV) emerged in 2012. Recently the MERS-24 CoV receptor dipeptidyl peptidase 4 (DPP4) was identified and the specific interaction of the receptor-25 binding domain (RBD) of MERS-CoV spike protein and DPP4 was determined by crystallography. 26 Animal studies identified rhesus macaques but not hamsters, ferrets or mice to be susceptible for MERS-27 CoV. Here we investigated the role of DPP4 in this observed species tropism. Cell lines of human and 28 non-human primate origin were permissive of MERS-CoV, whereas hamster, ferret or mouse cell lines 29 were not, despite presence of DPP4. Expression of human DPP4 in non-susceptible BHK and ferret cells 30 enabled MERS-CoV replication, whereas expression of hamster or ferret DPP4 did not. Modeling the 31 binding energies of MERS-CoV spike protein RBD to DPP4 of human (susceptible) or hamster (non-32 susceptible) identified five amino acid residues involved in the DPP4-RBD interaction. Expression of 33 hamster DPP4 containing the five human DPP4 amino acids rendered BHK cells susceptible to MERS-34 CoV, whereas expression of human DPP4 containing the five hamster DPP4 amino acids did not. Using 35 the same approach, the potential of MERS-CoV to utilize the DPP4s of common Middle Eastern livestock 36 was investigated. Modeling of the DPP4 MERS-CoV RBD interaction predicted the ability of MERS-37 CoV to bind the DPP4s of camel, goat, cow and sheep. Expression of the DPP4s of these species on BHK 38 cells supported MERS-CoV replication. This suggests, together with the abundant DPP4 presence in the 39 respiratory tract, that these species might be able to function as a MERS-CoV intermediate reservoir. 40 41 predict that based on the ability of MERS-CoV to utilize the DPP4 of common Middle East livestock 50 species, such as camels, goats, sheep and cows, these form a potential MERS-CoV intermediate host 51 reservoir species. 52 53
Importance 42
The ongoing outbreak of Middle East Respiratory Syndrome coronavirus (MERS-CoV) has caused 184 43 laboratory confirmed cases to date, with 80 fatalities. Although bats and dromedary camels have been 44 identified as potential MERS-CoV hosts, the virus has so far not been isolated from any species other 45 than humans. The inability of MERS-CoV to infect commonly used animal models such as hamster, mice 46 and ferrets, indicates the presence of a species barrier. We show that the MERS-CoV receptor DPP4 plays 47 a pivotal role in the observed species tropism of MERS-CoV and subsequently identified the amino acids 48 in DPP4 responsible for this restriction. Using a combined modeling and experimental approach we 49 Introduction 54 55
The Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in 2012 in a patient 56 from Saudi-Arabia (1). To date, 496 laboratory confirmed cases have been reported in eight different 57 countries, with an estimated 20-25% case fatality rate (2). MERS-CoV is a positive strand RNA virus 58 belonging to the C lineage within the Betacoronavirus genus and is genetically closely related to 59 coronavirus sequences obtained from insectivorous bats originating from Europe, Asia, Africa and the 60 Middle East (1, 3-5). The detection of MERS-CoV neutralizing antibodies as well as the recovery of viral 61 sequences and virus in dromedary camels across the countries of the Middle East suggests the potential 62 involvement of an intermediate reservoir in the emergence of MERS-CoV in humans (6-10). 63
Phylogenetic analysis of MERS-CoV genomes obtained from 43 human cases in Saudi Arabia suggests 64 the occurrence of multiple zoonotic spill-over events (11, 12) . 65
Similarly to Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), another Betacoronavirus 66 which caused the SARS pandemic, MERS-CoV appears to primarily target the lower respiratory tract 67 causing acute respiratory distress in severe human cases (2, 13, 14) . However, in contrast to SARS-CoV, 68 which uses angiotensin converting enzyme 2 (ACE2) as its cellular host receptor (15), MERS-CoV 69 utilizes dipeptidyl peptidase 4 (DPP4, also known as CD26) (16). Interaction of the receptor binding 70 domain (RBD) of the MERS-CoV spike protein with DPP4 initiates attachment to the host cell and 71 subsequent virus internalization. The RBD was mapped to be a 231 amino acid region in the S1 subunit of 72 the spike protein (17). DPP4 is a type II transmembrane glycoprotein, involved in cleavage of dipeptides 73 and degradation of incretins (18). DPP4 is widely expressed in different tissues, such as lungs and kidney 74 and the cells of the immune system, although a detailed description of DPP4 expression in the human 75 respiratory tract and kidney is currently not available. DPP4 is relatively conserved between mammalian 76 species, allowing the MERS-CoV spike protein to bind to both bat and human DPP4 (16, 18) . 77
In vitro studies using a variety of different primary and immortalized cell lines reported a broad tropism 78 of MERS-CoV (19-22). Most cell lines with a human-, bat-, non-human primate-or swine-origin were 79 found to be susceptible to infection with MERS-CoV. In contrast, cell lines originating from mice, 80 hamsters, dogs and cats were not susceptible to MERS-CoV infection (16, 19 Glutamine, 50 U/ml penicillin and 50 g/ml of streptomycin (culture DMEM). Primary ferret kidney cells 111 were generated as follows: within 30 minutes of tissue collection, the fibrous capsule, adjacent medulla 112 and any fat, blood cloths and connective tissue were dissected from the ferret kidney which was 113 subsequently cut into small pieces. The tissue sample was washed with ice-cold Hank's balanced salt 114 solution (HBSS) containing 10 mM EGTA until the supernatant was clear and further cut into 1 mm 3 115 pieces. Hereafter, the tissue sample was incubated at 37°C for 20 minutes whilst rolling in 25 ml of warm 116 non-supplemented DMEM/F12 GlutaMAX media containing 1 mg/ml collagenase (Worthington) and 117 passed through a 100 μm sieve, a 70 μm sieve and a 40 μm sieve. Supernatant was centrifuged at 400 g 118 for 5 min at 4 °C and washed 3 times with HBSS. The pellet was then resuspended in DMEM/F12 119 GlutaMAX media supplemented with 10% FBS, 50 U/ml penicillin, 50 g/ml of streptomycin, 2.5 μg/ml 120 Fungizone and 5 μg/ml human transferrin (Sigma Aldrich) and cells were seeded at a density of 5 x 10 4 121 cells/cm 2 . The ferret primary kidney cell line was maintained in DMEM/F12 + GlutaMAX supplemented 122 with 10% FBS, 50 U/ml penicillin, 50 g/ml of streptomycin, 2.5 μg/ml Fungizone and 50 μg/ml human 123 transferrin. All cell lines were maintained at 37°C in 5% CO 2 . All reagents were purchased from Gibco, 124 unless otherwise specified. MERS-CoV (strain HCoV-EMC/2012) was propagated on VeroE6 cells 125 using DMEM supplemented with 2% FBS, 2 mM L-Glutamine, 50 U/ml penicillin and 50 g/ml of 126 streptomycin (complete DMEM). MERS-CoV was titrated by end-point titration in quadruplicate in 127 VeroE6 cells cultured in complete DMEM as follows: cells were inoculated with ten-fold serial dilutions 128 of virus, and scored for cytopathic effect 5 days later. One hour after inoculation, cells were washed once with DMEM and fresh media was placed on the cells. 184
Supernatants were sampled at 0, 24, 48 and 72 h after inoculation, and virus titers in these supernatants 185 were determined as described. Figure 1A) . These data 230 correspond with the current information on the ability of MERS-CoV to infect humans and non-human 231 primates (rhesus macaques (23, 25)) and the inability of MERS-CoV to infect mice, hamsters and ferrets 232 (24, 26, 27) . The presence of the MERS-CoV receptor, DPP4, is essential in the initiation of infection. To 233 investigate whether the lack of infection by MERS-CoV of non-susceptible cell lines was due to a lack of 234 expression of the DPP4 receptor we performed western blot analyses. DPP4 protein was detected in cell 235 lines both permissive and non-permissive for MERS-CoV infection although not uniformly found to be 236 expressed on the cell surface ( Figure 1B, C) . 237 238
Detection of DPP4 in tissues 239
To determine the cell types in which DPP4 was expressed in the lungs and kidney of rhesus macaque, 240 hamster, mouse and ferret, immunohistochemistry (IHC) was performed using an -DPP4 antibody. In 241 both the lungs and kidneys of the investigated species, DPP4 was found to be present. In the lungs, DPP4 242 was abundantly present on bronchiolar epithelium cells and occasionally present on alveolar interstitium, 243 or absent in the case of ferrets (Figure 2, Table 1 ). The intensity of the -DPP4 staining of bronchiolar 244 epithelium ranged from weak in ferrets, to moderate in the macaque and hamster and very intense in the 245 mouse. All species tested, except the ferret, also demonstrated weak -DPP4 immunoreactivity at the 246 level of alveoli. The kidney was similar to lung tissue in that all species demonstrated -DPP4 247 immunoreactivity to epithelial cells. The intensity of staining was again variable, with weak staining in 248 the hamster, moderate staining in the macaque and mouse and intense staining in ferret. DPP4 was present 249 on kidney vascular smooth muscle cells, with weak staining in the macaque, mouse, ferret and moderate 250 staining in the hamster. All species except the mouse displayed presence of DPP4 on either glomerular or 251 vascular endothelium with the strongest staining seen in the glomeruli of hamsters and ferrets. Table 2) . To investigate the binding potential of the different DPP4s to MERS-CoV 275 spike protein, DPP4 homology models were built using the human DPP4 structure (PDB ID: 4KR0, 276
Chain A) as a template (36). Of the five amino acid residues at the RBD interface that differ between 277 human and hamster DPP4, the residues at positions 291 and 336 appear to be most critical for the species 278 specificity. In the human DPP4:RBD crystal structure, the small methyl side chain of Ala291 in DPP4 279 nestles into a small pocket in the RBD, which cannot accommodate the size and charge of the 280 corresponding glutamic acid residue found in the hamster DPP4 molecule. This steric clash alone is likely 281 sufficient to abrogate binding. In addition, the side chain of Arg336 in human DPP4 forms hydrogen 282 bonds with RBD residue Tyr499 and a salt bridge to RBD residue Asp455. These interactions would not 283 be formed by the corresponding threonine side chain in hamster DPP4. The remaining three DPP4 284 residues at the RBD interface that differ in humans and hamsters are conserved substitutions and are not 285 predicted to greatly impact binding to the RBD (Figure 4A) . Furthermore, these analyses showed that 286 hamster DPP4 has significantly higher binding energy (less favorable interactions) than human DPP4 to 287 MERS-CoV ( Figure 4B) . When mutant DPP4s were designed in silico by introducing the five human-288 specific amino acid residues (Ala291, Ile295, Arg336, Val341 and Ile346) into the hamster DPP4 289 (humanized hamster DPP4), and the five hamster-specific amino acid residues (Glu291, Thr295, Thr336, 290 The modeling data suggested that introduction of the five human-specific amino acid residues in hamster 298
DPP4 would allow recognition of this DPP4 by the MERS-CoV spike protein. To test this hypothesis, 299
expression plasmids were synthesized with human DPP4 containing the five hamster-specific amino acid 300 residues (hamsterized human DPP4) and hamster DPP4 containing the five human-specific amino acid 301 residues (humanized hamster DPP4). Inoculation of BHK cells transiently expressing humanized hamster 302
DPP4 with MERS-CoV resulted in virus replication, whereas inoculation of BHK cells transiently 303
expressing hamsterized human DPP4 did not ( Figure 5A) . Expression of DPP4 on BHK cells was 304 confirmed via flow cytometry ( Figure 5B) . 305 306
Modeling and in vitro characterization of the DPP4 of putative intermediate host species 307
We determined the binding energy of DPP4s to MERS-CoV spike protein of known binders (rhesus 308 macaque) and non-binders (ferret and mouse). Like hamster DPP4, the binding energy of ferret and mouse DPP4 to MERS-CoV spike protein was found to be relatively high. In contrast, rhesus macaque 310 DPP4 was found to have binding energy levels similar to human DPP4 ( Figure 4B) . These results were 311 confirmed in vitro by transfecting BHK cells with DPP4 from rhesus macaque and subsequently 312 inoculating these cells with MERS-CoV, resulting in virus replication. In contrast, transfection of the 313 DPP4 of ferret or mouse origin into DPP4 did not render these cells susceptible to MERS-CoV replication 314 ( Figure 6) was found to be relatively low, suggesting these proteins can function as a receptor for MERS-CoV 319 ( Figure 4B) . Furthermore, expression of dromedary camel, goat, sheep and cow DPP4 on BHK cells 320 supported replication of MERS-CoV ( Figure 6A) . Expression of DPP4 on BHK cells was confirmed via 321 flow cytometry and qRT-PCR ( Figure 6B, C) . DPP4 was detected on cells in lung and kidney tissue of 322 camel, goat, cow, and sheep by IHC. Interestingly, DPP4 was more abundantly expressed on alveolar 323 interstitium in cow, goat and sheep lungs compared to dromedary camel, rhesus macaque, hamster, mouse 324 and ferret lungs (Figure 7, Table 1 ). Finally, we carried out full-length and partial (DPP4 binding domain, 325 amino acids 220-350) protein sequence alignments between DPP4 of camel, goat, cow and sheep. Camel 326 DPP4 diverged from goat, cow, and sheep DPP4, in particular when comparing partial DPP4 protein 327 sequences ( Table 3) . from a wide variety of mammalian species (bats, non-human primates, pigs, and humans), it was speculated to have a broad host tropism (19, 21). However, it is currently unclear whether in vitro results 336 correlate directly with in vivo susceptibility (38). MERS-CoV was found to be unable to infect some of 337 the major respiratory animal models (Syrian hamster, mouse and ferrets (24, 26, 27)) in contrast to the 338 ability of MERS-CoV to replicate efficiently in rhesus macaques (23). This suggests the existence of a 339 host-barrier restriction of MERS-CoV for some species. Using in vitro growth kinetics of MERS-CoV we 340 were able to demonstrate this host-species restriction in cell lines from different mammalian origins. 341 MERS-CoV replicated efficiently in cells of human and non-human primate origin, but was not able to 342 replicate in cells of mouse, hamster or ferret origin, despite the presence of DPP4 (Figure 1) . Analysis of 343 the presence of DPP4 in Syrian hamster, mouse and ferret lung and kidney tissues as well as the rhesus 344 macaque lung and kidney tissues suggested that the inability of MERS-CoV to infect Syrian hamster, 345 mouse and ferret is not due to a lack of expression of the DPP4 receptor ( Figure 2) . Our hypothesis that 346 the host species restriction of MERS-CoV lies on the receptor-binding level was supported by the lack of 347 replication in hamster and ferret cells upon exogenous expression of the hamster or ferret DPP4 on the 348 surface of these cells, whereas expression of the human DPP4 receptor rendered these previously non-349 permissive cell lines permissive for MERS-CoV (Figure 3) . We observed a >2 log difference in growth of 350 MERS-CoV between hamster and ferret cells, which may be explained by the difference in transfection 351 efficiency (BHKs, 93.0%; primary ferret cells, 65.8%; Figure 3B ). The co-crystallization between the 352 human DPP4 and the MERS-CoV spike protein revealed the receptor binding domain of MERS-CoV and 353 the amino acid residues of human DPP4 interacting with this domain (36, 37). Alignment of DPP4 amino 354 acid residues identified as interacting with the MERS-CoV spike protein between human and rhesus 355 DPP4s (binders) and hamster DPP4 (non-binder) revealed a minimal subset of five amino acid changes 356 between the human and the hamster DPP4 ( Table 2 ). These five differential human amino acid residues 357 were introduced into the hamster DPP4 (humanized hamster DPP4) and the five differential hamster 358 amino acid residues were introduced into the human DPP4 (hamsterized human DPP4). Expression of the 359 humanized hamster DPP4 in BHK cells rendered these cells permissive for MERS-CoV, whereas 360 expression of hamsterized human DPP4 did not change the non-permissiveness of the cells ( Figure 5) .
For ferret DPP4 it was recently shown that exchanging the 246 to 505 amino acid region with that of 362 human DPP4 resulted into the ability of MERS-CoV to utilize this chimeric DPP4 (28), as was the case 363 for mouse DPP4 when exchanging amino acids 279 to 346 with the human DPP4 counterpart (29). In 364 addition, both of these studies found amino acids to be important in spike binding that were identified in 365 this study (295, 336 and 346 for mouse and 295, 336 and 341 for ferret) (28, 29). Interestingly, although 366 the humanized hamster DPP4 was able to facilitate MERS-CoV infection, MERS-CoV titers were 367 considerably lower. This could indicate that although substitution of five human amino acids into hamster 368 DPP4 is sufficient for spike binding, additional amino acid residues in the interface might be required for 369 optimal binding and infectivity. Subsequent modeling between DPP4s of species known to be able to bind MERS-CoV spike protein 378 (human and rhesus macaque) and species known not to be able to bind MERS-CoV spike protein 379 (hamster, mouse and ferret) displayed a stark difference in binding energies between binders and non-380 binders. Utilizing the same model, DPP4s of species implicated in the emergence of MERS-CoV 381 (dromedary camel, sheep, goat and cow) were predicted to be able to bind to the spike protein of MERS-382 CoV ( Figure 4B ). DPP4 modeling data was supported by experimental work showing that indeed the 383 DPP4s of dromedary camel, sheep, goat and cow were able to support MERS-CoV replication ( Figure 6) . 384 MERS-CoV-like antibodies have been found in dromedary camels, but not yet in goat, sheep or cow 385 species (7, 44). However, DPP4 from goat, cow and sheep can function as a receptor for MERS-CoV, 386 although with lesser efficiency (Figure 6) . Protein sequence alignments of full-length and partial DPP4 revealed that camel DPP4 differs from goat, cow and sheep DPP4, in particular when amino acids 220-388 350 of DPP4, which are of importance in spike binding, were investigated ( Table 3) 
